Menorrhagia Clinical Trial
Official title:
Minerva Pivotal Study
The primary objective of this study is to evaluate the safety and effectiveness of the Aurora Endometrial Ablation System as compared to hysteroscopic rollerball endometrial ablation in reducing menstrual blood loss at 12 months post-treatment.
Menorrhagia is defined as menstrual bleeding in the ovulatory woman exceeding 80 ml per month. Approximately 20-25% of healthy premenopausal women have abnormal uterine bleeding. Menorrhagia can have a negative impact on a woman's lifestyle and self-perception, often leading her to seek definitive treatment. Pharmacologic treatment for menorrhagia is not always successful, and dilatation and curettage typically provides relief for only a few menstrual cycles. Traditionally hysterectomy has been the definitive treatment for menorrhagia. This clinical study evaluates the safety and effectiveness of the Aurora Endometrial Ablation System to provide a therapeutic treatment for menorrhagia due to benign causes by ablating the endometrial lining of the uterus in pre-menopausal women for whom childbearing is complete. Subjects who are randomized to the control group will receive hysteroscopic rollerball/resection ablation. Subjects randomized to the test arm will be treated with the Aurora Endometrial Ablation System. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02824224 -
Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)
|
Phase 4 | |
| Withdrawn |
NCT01651468 -
The Effect of the Nutraceutical "Hemofix" on the Coagulation System
|
N/A | |
| Recruiting |
NCT02616731 -
Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD
|
Phase 1/Phase 2 | |
| Terminated |
NCT02087228 -
Evaluation of the Endometrial Cavity After Endometrial Ablation
|
N/A | |
| Withdrawn |
NCT00953641 -
Vaginal Misoprostol for Cervical Ripening Prior to Endometrial Biopsy
|
Phase 3 | |
| Completed |
NCT01436903 -
Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length
|
Phase 4 | |
| Withdrawn |
NCT00768742 -
Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study
|
N/A | |
| Completed |
NCT00156195 -
Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids
|
Phase 3 | |
| Completed |
NCT00152256 -
A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids
|
Phase 3 | |
| Completed |
NCT00160381 -
A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids
|
Phase 3 | |
| Completed |
NCT02228174 -
Sonography Guided Transcervical Ablation of Uterine Fibroids
|
N/A | |
| Terminated |
NCT01969396 -
Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology
|
N/A | |
| Completed |
NCT00393198 -
Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia
|
Phase 4 | |
| Completed |
NCT00386308 -
Efficacy and Safety Study of XP12B in Women With Menorrhagia
|
Phase 3 | |
| Completed |
NCT00966264 -
Hysterectomy and Levonorgestrel Releasing Intrauterine System (LNG-IUS) in the Treatment of Menorrhagia
|
Phase 3 | |
| Completed |
NCT00904709 -
The Assessment of Tranexamic Acid in Women With Menorrhagia Who Have Bleeding Disorders
|
Phase 4 | |
| Recruiting |
NCT03670680 -
Efficiency of Lina LibrataTM System
|
N/A | |
| Completed |
NCT02584088 -
Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation
|
||
| Completed |
NCT02835391 -
PerClot Compared to Usual Care in Gynaecology Procedures
|
N/A | |
| Completed |
NCT02304510 -
Prevalence of Heavy Menstrual Bleeding in Female Population Living in Beijing
|